REPROCELL

This Diwali, REPROCELL USA has even more to celebrate. From October 20–24, Maryland Economic Development Week recognizes the vital role local businesses play in driving growth and creating opportunities across the state. This year, the Prince George’s County Economic Development Corporation honored REPROCELL USA with a Certificate of Recognition for our contributions to the county’s and Maryland’s economic vitality. “In grateful appreciation for your valued contributions to the economic growth and vitality of Prince George’s County and the State of Maryland. Your commitment to innovation and community enrichment exemplifies the spirit of Economic Development Week.” We’re proud to be part of a thriving community that values innovation and collaboration. To learn more about how REPROCELL can support your research, please visit https://hubs.li/Q03PPpzk0

𝗡𝗲𝘄 𝗿𝗲𝗮𝗱𝘆-𝘁𝗼-𝘂𝘀𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝗴𝗿𝗮𝗱𝗲 𝗶𝗣𝗦𝗖 𝗰𝗹𝗼𝗻𝗲𝘀 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗻𝗼𝘄 𝗳𝗼𝗿 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻! We are excited to add a 23-year-old, Caucasian male (A⁺ blood type) donor line to our StemRNA™ clinical iPSC portfolio. Multiple iPSC clones from this donor are now ready for testing — the perfect foundation for advancing your cell therapy development. Each clone is generated using REPROCELL’s RNA reprogramming technology, ensuring footprint-free, fully consented, and globally compliant iPSCs that meet FDA, EMA, and PMDA donor eligibility requirements. Want to find out more details about this cell line? Contact our experts: 𝗶𝗻𝗳𝗼-𝗲𝗺𝗲𝗮@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹.𝗰𝗼𝗺 Explore our StemRNA™ clinical iPSC lines: https://hubs.li/Q03PSDPF0

High-quality biospecimens. Global reach. Ethical sourcing. From early discovery to late-stage clinical trials, reliable human tissue samples are vital for credible research. At REPROCELL, our Bioserve Global Biorepository houses over 600,000 biospecimens collected under strict IRB oversight.When specific samples aren’t in-house, our global partner network and custom collection services ensure you get the right specimens, fast. Learn how REPROCELL supports researchers worldwide with data-rich, ethically sourced human biospecimens. https://hubs.li/Q03PQDDF0

Thank you for visiting REPROCELL at 𝗘𝗟𝗥𝗜𝗚’𝘀 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝟮𝟬𝟮𝟱 in Liverpool! It was a pleasure connecting with so many of you! Our CEO of REPROCELL Europe, 𝗗𝗿. 𝗗𝗮𝘃𝗶𝗱 𝗕𝘂𝗻𝘁𝗼𝗻, delivered a highly successful 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 presentation! If you didn’t get a chance to sop by, let’s keep the conversation going: 👉 Contact us here: https://hubs.li/Q03PPqRs0 Discover more about our services: • 𝗣𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗖𝗥𝗢 (Safety Pharmacology Services in human fresh tissues): https://hubs.li/Q03PPrcH0 • 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆-𝗔𝗜 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PPpsy0 • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PPsvT0 • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘁𝗲𝗺 𝗖𝗲𝗹𝗹 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PPs130 • 𝗣𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗚𝗲𝗻𝗼𝗺𝗶𝗰 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PPscg0 We look forward to future collaboration and continuing the conversation started at ELRIG Drug Discovery 2025! #DrugDiscovery2025 #Biotech #DrugDiscovery #ELRIGDD2025 #REPROCELL

Following our recent post announcing that REPROCELL USA, Inc. was awarded the Maryland Stem Cell Research Fund (MSCRF) Manufacturing Assistance grant, we are excited to share more details about this milestone in our journey. 🔬 What’s next? We are now advancing the development of a 𝗳𝘂𝗹𝗹-𝘀𝗰𝗮𝗹𝗲 𝗚𝗠𝗣/𝗖𝗗𝗠𝗢 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝘆 in Maryland to support large-scale manufacturing of hiPSC-derived and MSC therapies. This investment deepens our ability to serve scientists and biotechs with turnkey GMP capabilities - banking, differentiation, gene-editing and large-batch cell therapy production under one roof. 💡Why this matters:   • Expands capacity for clinical-grade stem cell manufacturing   • Enables more robust service offerings to accelerate your research and development   • Strengthens Maryland’s position in regenerative medicine through collaboration with MSCRF and our team You can read the full press release here: https://hubs.li/Q03PGxWh0

Introducing Alvetex® Advanced — Next-Generation 3D Tissue Modeling by REPROCELL We’re excited to unveil Alvetex® Advanced, our most innovative 3D bioengineering platform. Designed for researchers pushing the boundaries of biology, it delivers tissue models that truly mimic human physiology — for better science, better data, and more confident decisions. Key advantages: • Realistic 3D human tissue architecture • Leak-free design with minimal edge effects • Non-invasive readouts (pH, TEWL, TEER, etc.) • Seamless modular integration across formats From skin models to barrier testing, Alvetex® Advanced sets a new standard for in vitro research in pharma, cosmetics, and device testing. https://hubs.ly/Q03Ph1Y80

Day 1 of 𝗘𝗟𝗥𝗜𝗚’𝘀 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝟮𝟬𝟮𝟱 kicks off today in Liverpool! We are excited to welcome you at 𝗕𝗼𝗼𝘁𝗵 #𝗕𝟬𝟳. Stop by 𝗕𝗼𝗼𝘁𝗵 #𝗕𝟬𝟳 to meet our Drug Discovery experts, 𝗗𝗮𝘃𝗶𝗱, 𝗔𝗯𝗯𝗶𝗲, 𝗡𝗮𝘆𝗲𝗲𝗺 𝗮𝗻𝗱 𝗘𝗹𝗹𝗮-𝗥𝗼𝘀𝗲 —and explore our innovative solutions: • 𝗣𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗖𝗥𝗢 (Safety Pharmacology Services in human fresh tissues): https://hubs.li/Q03Prvj90 • 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆-𝗔𝗜 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03Prwfl0 • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PrtCc0 • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘁𝗲𝗺 𝗖𝗲𝗹𝗹 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PrtD70 • 𝗣𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗚𝗲𝗻𝗼𝗺𝗶𝗰 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: https://hubs.li/Q03PrvDB0 📍 Don’t miss today! 𝗗𝗿. 𝗗𝗮𝘃𝗶𝗱 𝗕𝘂𝗻𝘁𝗼𝗻’𝘀 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 🗓️ Tue, 21 Oct | ⏰ 14:30 | 📌 Auditorium 2 Topic: “𝗧𝗵𝗲 𝗨𝘀𝗲 𝗼𝗳 𝗛𝘂𝗺𝗮𝗻 𝗙𝗿𝗲𝘀𝗵 𝗧𝗶𝘀𝘀𝘂𝗲𝘀 𝗮𝗻𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗗𝗮𝘁𝗮 𝗳𝗼𝗿 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲” Let’s connect in Liverpool! 🔗 Event details: https://hubs.li/Q03PrtHS0 #DrugDiscovery2025 #Biotech #DrugDiscovery #ELRIGDD2025 #REPROCELL

Milestone Achievement: 𝗔𝗘𝗠𝗣𝗦 𝗚𝗠𝗣 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 for 𝗶𝗣𝗦𝗖 and 𝗖𝗲𝗹𝗹 𝗕𝗮𝗻𝗸 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 We are excited to announce that REPROCELL and Histocell. Regenerative Medicine have jointly achieved AEMPS GMP certification for the manufacturing of 𝗶𝗣𝗦𝗖 𝗠𝗮𝘀𝘁𝗲𝗿 & 𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗖𝗲𝗹𝗹 𝗕𝗮𝗻𝗸𝘀 using REPROCELL’s 𝗦𝘁𝗲𝗺𝗥𝗡𝗔™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖𝘀, produced at Histocell’s newly certified GMP facility in Spain. This certification, granted by AEMPS, Spain’s regulatory authority operating under the European Medicines Agency (EMA), covers not only iPSCs but also cell banking processes in general, building on Histocell’s existing GMP accreditation for MSC manufacturing. The certification ensures EMA-aligned manufacturing standards that are also compatible with FDA and other global regulatory expectations, supporting the production of clinical-grade iPSC and MSC products for global cell therapy programs. Together, REPROCELL and Histocell are strengthening the foundation for globally scalable, regulatory-compliant GMP manufacturing, bringing next-generation regenerative therapies closer to patients worldwide. Learn more: https://hubs.li/Q03PgkGb0 Check out our GMP iPSC & MSC capabilities via Histocell: https://hubs.li/Q03Pgk3n0 #REPROCELL #Histocell #GMP #iPSC #CellTherapy #Biotech #RegenerativeMedicine #Innovation

We’re proud to support Cancer Research UK in their mission to beat cancer. One of our perfusion plates was recently featured in their latest television campaign — highlighting the groundbreaking research that has helped double cancer survival rates in the UK over the past 50 years. At REPROCELL, we’re honoured that our technologies can play a significant part in enabling the kind of discoveries that lead to earlier diagnosis, more effective treatments, and improved quality of life for patients around the world. A huge thank you to the incredible scientists and teams at Cancer Research UK for their relentless dedication to saving lives. Watch the campaign and learn more: https://hubs.li/Q03P4yFM0

In our recent webinar 𝗗𝗿. 𝗟𝘂𝗮𝗻𝗮 𝗙𝗲𝗿𝗿𝗮𝗿𝗮 presented how 𝗤𝗸𝗶𝗻𝗲’𝘀 high-purity, animal-free 𝗴𝗿𝗼𝘄𝘁𝗵 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 and 𝗰𝘆𝘁𝗼𝗸𝗶𝗻𝗲𝘀 are engineered with rigorous quality control to tackle the reproducibility challenges in stem cell, organoid, and disease model systems. Couldn’t join us live? The 𝗳𝘂𝗹𝗹 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 is now online, on our 𝗬𝗼𝘂𝗧𝘂𝗯𝗲 channel. ▶️ Link to the recording: https://hubs.ly/Q03MVw-D0 🔍 Explore Qkine's grow factors & cytokines: https://hubs.ly/Q03MVrZL0